• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON SURGICAL VISION, INC. HEALON ENDOCOAT; OVDS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON SURGICAL VISION, INC. HEALON ENDOCOAT; OVDS Back to Search Results
Model Number HEALON ENDOCOAT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Inflammation (1932)
Event Date 09/26/2020
Event Type  Injury  
Manufacturer Narrative
If implanted; give date: n/a (not applicable).The healon endocoat is not an implantable device.If explanted; give date: n/a (not applicable).The healon endocoat is not an implantable device.(b)(4).All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Event Description
It was reported that toxic anterior segment syndrome (tass) occurred in the left eye of a patient which was implanted with an intraocular lens.Moxifloxacin ophthalmic eye drops were given as a normal pre and post regimen.The patient was also taking durezol eye drops every 1-2 hours.In addition, the patient was given a medrol dose pak 4mg tablets po (use as directed) on (b)(6) 2020 post surgery.It was noted that the patient has recovered.The lens remains in the patient's eye.The account indicated that they have been doing an investigation and at this point they do not know where the tass is coming from.No further information was provided.This emdr report is for the healon endocoat device.A separate emdr will be submitted for the intraocular lens, model zcu450.
 
Manufacturer Narrative
Additional information/corrected data: additional information received indicated that the post-op drops given to the patient were moxifloxacin, ketorolac, prednisolone.Also, initially the account reported ''(b)(6) 1950'' to be the date of birth for the patient which was entered in the initial emdr report.However, additional information received from the account clarified that the correct date of birth for the patient is ''(b)(6) 1950''.Therefore the following field was updated accordingly: section a2: age/date of birth: (b)(6) 1950.Upon further review of the complaint file, it was noted that the event reported for the healon endocoat product, lot 028612 under the manufacturer #3004750704-2020-00075 was a duplicate of an earlier event which had already been reported under the manufacturer report #3004750704-2020-00054.Therefore, no further information will be provided under this medwatch #3004750704-2020-00075 as it has now been determined to be a duplicate report.All pertinent information available to johnson and johnson surgical vision, inc.Has been submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEALON ENDOCOAT
Type of Device
OVDS
Manufacturer (Section D)
JOHNSON & JOHNSON SURGICAL VISION, INC.
1700 e st andrew place
santa ana CA 92705
MDR Report Key11062302
MDR Text Key223372800
Report Number3004750704-2020-00075
Device Sequence Number1
Product Code LZP
UDI-Public(01)(17)220331(10)028612
Combination Product (y/n)Y
PMA/PMN Number
P110007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other,use
Type of Report Initial,Followup
Report Date 01/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/23/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/31/2022
Device Model NumberHEALON ENDOCOAT
Device Catalogue Number51031000
Device Lot Number028612
Was Device Available for Evaluation? No
Date Manufacturer Received12/22/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
LENS MODEL ZCU450, SN (B)(6); LENS MODEL ZCU450, SN (B)(4)
Patient Outcome(s) Other;
Patient Age69 YR
-
-